Chronic diarrhea, defined as loose stools persisting for over four weeks, presents a diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive approach to diagnosing and managing this common but complex condition in clinical practice.
Diagnosis should begin with a detailed medical history, including onset, duration, frequency, and characteristics of the diarrhea, as well as associated symptoms. A thorough physical examination should follow, focusing on signs of dehydration, malnutrition, or systemic disease. Laboratory tests, including complete blood count, stool studies, and thyroid function tests, can provide further insights. When necessary, endoscopic examinations and imaging studies may be employed.
Common causes of chronic diarrhea include irritable bowel syndrome, inflammatory bowel disease, malabsorption syndromes, and chronic infections. Less common causes include endocrine disorders, such as hyperthyroidism, and malignancies. Identifying the cause can often be challenging due to overlapping symptoms and the need for specialized tests.
Treatment should be tailored to the underlying cause. Symptomatic relief can be achieved with antidiarrheal agents, dietary modifications, and probiotics. For inflammatory causes, immunosuppressive agents may be required. In cases of malabsorption, nutritional supplementation and dietary modifications are key. Antibiotics may be necessary for chronic infections. Early referral to a gastroenterologist should be considered for complex cases.
Chronic diarrhea is a complex condition requiring a comprehensive diagnostic approach and tailored treatment strategies. A thorough history and physical examination, along with appropriate laboratory and imaging studies, are crucial for accurate diagnosis. Treatment should be etiology-specific and may require a multidisciplinary approach. Through a better understanding of this condition, clinicians can improve patient outcomes and quality of life.
1.
Year in Review: Non-Small Cell Lung Cancer
2.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
5.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
1.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
2.
The Danger of Methemoglobinemia and How to Prevent It
3.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Thromboprophylaxis In Medical Settings
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation